MEDIROM Healthcare Technologies Inc. 在日本提供全面的醫療保健服務。該公司總部位於日本東京。
財務指標
營業收入
2026-03-31
$611.98M
2025-12-31
$611.98M
2025-09-30
$3.15B
2025-03-31
$4.82B
營業支出
2026-03-31
$539.22M
2025-12-31
$539.22M
2025-09-30
$1.15B
2025-03-31
$1.05B
淨利潤
2026-03-31
$63.42M
2025-12-31
$63.42M
2025-09-30
-$671.05M
2025-03-31
$730.94M
淨利潤率
2026-03-31
10.36%
2025-12-31
10.36%
2025-09-30
-21.28%
2025-03-31
15.15%
每股收益
2026-03-31
--
2025-12-31
--
2025-09-30
$-87.38
2025-03-31
$110.27
息稅折舊攤銷前利潤
2026-03-31
$83.37M
2025-12-31
$83.37M
2025-09-30
-$569.82M
2025-03-31
$828.06M
有效稅率
2026-03-31
1.26%
2025-12-31
1.26%
2025-09-30
-0.01%
2025-03-31
-14.87%
項目
2026-03-31
2025-12-31
2025-09-30
2025-03-31
營業收入
$611.98M
$611.98M
$3.15B
$4.82B
營業支出
$539.22M
$539.22M
$1.15B
$1.05B
淨利潤
$63.42M
$63.42M
-$671.05M
$730.94M
淨利潤率
10.36%
10.36%
-21.28%
15.15%
每股收益
--
--
$-87.38
$110.27
息稅折舊攤銷前利潤
$83.37M
$83.37M
-$569.82M
$828.06M
有效稅率
1.26%
1.26%
-0.01%
-14.87%
常見問題
MRM is a publicly traded equity identified by its ticker symbol on a U.S. stock exchange. It represents a fractional ownership stake in the underlying company, giving shareholders a claim on residual earnings and assets. The stock's price reflects market expectations about that company's future performance and risk. For the exact corporate name, exchange, and business description tied to MRM, refer to the latest company profile data shown on this page.
MRM's price can be influenced by company-specific developments such as earnings results, management guidance, capital allocation decisions, and operational updates. Broader forces also matter, including sector trends, interest rates, inflation, and overall market sentiment. Supply and demand for the shares, liquidity, and investor positioning can amplify price moves. Reviewing timely news and MRM's financial disclosures can help investors understand which factors are currently driving the stock.
Valuation is typically assessed using multiples like price-to-earnings, price-to-sales, price-to-book, and enterprise value-to-EBITDA, along with growth and margin trends. Comparing MRM's multiples with its own history and with peer companies provides context. A single metric rarely tells the full story, so combining several measures and considering the quality of earnings is useful. Current valuation metrics for MRM appear in the data on this page.
MRM shares can generally be bought or sold in pre-market and after-hours sessions through many brokers, though liquidity is often thinner and spreads wider than during the regular trading day. Extended-hours trading carries additional risks, including larger price swings and reduced order depth. Availability depends on the broker and the exchange. For MRM's regular session hours and any applicable details, check the trading information displayed on this page.
Start with MRM's income statement, balance sheet, and cash flow statement to assess revenue growth, profitability, leverage, and cash generation. Key metrics include gross and operating margins, earnings per share, free cash flow, and return on equity. Comparing these figures across several periods and against industry peers helps identify trends. Up-to-date financial statements and reported results for MRM are available through the data on this page.
Risks for MRM include company-specific challenges such as competitive pressure, execution issues, customer concentration, or balance-sheet stress, as well as broader market and economic risks. Sector disruptions, regulatory changes, and interest-rate shifts can also affect performance. Liquidity and volatility may magnify losses in adverse conditions. Reviewing MRM's risk disclosures and the latest financial reports helps investors understand which risks are most relevant.